If it knew,   the company could argue it shouldn’t have to pay a bigger rebate   than the other. " "    That’s the same argument the PCMA video makes: that drug   companies would take that rebate information and use it to   collude with competitors.   " ’   Watch :   ’ ’ ’ "    